What are the ACC/AHA/HRS recommendations for use of antiarrhythmic agents in the treatment of ongoing atrial flutter (AFL)?

Updated: Nov 18, 2019
  • Author: Lawrence Rosenthal, MD, PhD, FACC, FHRS; Chief Editor: Jeffrey N Rottman, MD  more...
  • Print
Answer

Antiarrhythmic agents can be considered in patients with symptomatic, recurrent atrial flutter, with the drug choice depending on the patient's underlying heart disease and comorbidities. (Class IIa recommendation) Drug choices include the following:

  • Amiodarone
  • Dofetilide
  • Sotalol

​Flecainide or propafenone may be considered in patients without structural heart disease or ischemic heart disease who have symptomatic recurrent atrial flutter. (Class IIb recommendation)


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!